| Line item | 2026-01-03 FY | 2024-12-28 FY | 2023-12-30 FY | 2022-12-31 FY | 2022-01-01 FY | 2021-01-02 FY |
|---|---|---|---|---|---|---|
| Revenue | $14.80B | $13.70B | $13.68B | $12.87B | $12.38B | $11.65B |
| Cost of Revenue | – | – | – | – | – | $10.09B |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | $521.00M | $491.00M | $570.00M | $601.00M | $619.00M | $549.00M |
| SG&A | $1.17B | $1.16B | $1.23B | $1.19B | $1.22B | $1.04B |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | $142.00M | $166.00M |
| Tax Expense | $214.00M | $118.00M | $165.00M | $154.00M | $126.00M | -$27.00M |
| Net Income | $921.00M | $824.00M | $921.00M | $861.00M | $746.00M | $309.00M |
| EPS (basic) | 5.1500 | 4.3800 | 4.6100 | 4.0500 | 3.3300 | – |
| EPS (diluted) | 5.1100 | 4.3300 | 4.5600 | 4.0100 | 3.3000 | – |
| Shares (diluted) | $180.26M | $190.31M | $201.77M | $214.97M | $226.52M | $228.98M |